CORD-19:954e351a7d8b5d4c275b9af0b053ce983d334547 / 291796-292009 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/954e351a7d8b5d4c275b9af0b053ce983d334547","sourcedb":"CORD-19","sourceid":"954e351a7d8b5d4c275b9af0b053ce983d334547","text":"691 The recent development of NSAIDs that specifically inhibit COX-2 has markedly reduced the frequency and severity of gastrointestinal side effects in humans taking NSAIDs for chronic musculoskeletal conditions.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T293","span":{"begin":0,"end":213},"obj":"Sentence"}],"attributes":[{"subj":"T293","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T54573","span":{"begin":0,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T54573","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#a993ec","default":true},{"id":"CORD-19-Sentences","color":"#96ec93"}]}]}}